Details:
Under the agreement, Northway has already started developing a GMP-compliant manufacturing process of IMP761 and will manufacture IMP761 in large scale bioreactors. Planning for further pre-clinical and clinical development is ongoing.
Lead Product(s): IMP761
Therapeutic Area: Immunology Product Name: IMP761
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: Immutep
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement December 16, 2021